Cleared Special

K093224 - DENSICHECK PLUS

K093224 is the FDA 510(k) clearance for DENSICHECK PLUS by bioMerieux, Inc.. It is a Class 2 Microbiology device (product code LON) cleared through the Special 510(k) pathway after a 26-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2009
Decision
26d
Days
Class 2
Risk

K093224 is an FDA 510(k) clearance for the DENSICHECK PLUS. Classified as System, Test, Automated, Antimicrobial Susceptibility, Short Incubation (product code LON), Class II - Special Controls.

Submitted by bioMerieux, Inc. (Hazelwood, US). The FDA issued a Cleared decision on November 9, 2009 after a review of 26 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1645 - the FDA microbiology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all bioMerieux, Inc. devices

Submission Details

510(k) Number K093224 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 14, 2009
Decision Date November 09, 2009
Days to Decision 26 days
Submission Type Special
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 102d · This submission: 26d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code LON System, Test, Automated, Antimicrobial Susceptibility, Short Incubation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1645
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LON System, Test, Automated, Antimicrobial Susceptibility, Short Incubation

All 281
Devices cleared under the same product code (LON) and FDA review panel - the closest regulatory comparables to K093224.
VITEK 2 STRPTOCOCCUS AMPICILLIN
K112075 · bioMerieux, Inc. · Sep 2011
VITEK 2 AST-ST LINEZOLID
K111599 · bioMerieux, Inc. · Aug 2011
VITEK 2 GRAM POSITIVE DOXCYCLINE
K093076 · bioMerieux, Inc. · Oct 2010
MICROSCAN SYNERGIES PLUS MIC/COMBO PANELS, MODEL B1025
K092919 · Siemens Healthcare Diagnostics · Oct 2009
DENSICHEK PLUS
K083536 · bioMerieux, Inc. · Sep 2009
VITEK 2 GRAM NEGATIVE MEROPENEM
K091899 · bioMerieux, Inc. · Aug 2009